Comparison Between Laparoscopic and Open Resection Following Neoadjuvant Chemoradiotherapy for Mid-Low Rectal Cancer Patients: A Meta-Analysis

J Laparoendosc Adv Surg Tech A. 2019 Mar;29(3):316-322. doi: 10.1089/lap.2018.0409. Epub 2018 Aug 8.

Abstract

Introduction: The optimal approach of resection for mid-low rectal cancer after neoadjuvant chemoradiotherapy (nCRT) is still controversial. The aim of this meta-analysis was to clarify the safety and feasibility of laparoscopic surgery compared with open resection.

Materials and methods: We performed a literature search for studies on PubMed, Embase and Cochrane Library up to March 1, 2018. Review Manager software was applied for data analysis. We used weighted mean difference (WMD) for continuous parameters and odds ratio (OR) for dichotomous variables. Confidence interval (CI) was set at 95% and a P value <.05 was considered statistically significant.

Results: A total of seven studies met the inclusion criteria for the meta-analysis: 466 patients in laparoscopic group and 491 in open group. The pooled result revealed that laparoscopic resection had a favorable blood loss (WMD = -116.88 mL; 95% CI: -189.78 to -43.99; P = .002), analogous lymph nodes harvest (WMD = -0.30; 95% CI: -1.29 to 0.70; P = .56), less postoperative complications (OR = 0.63; 95% CI: 0.46-0.88; P = .006), shorter time to pass first flatus (WMD = -0.76 day; 95% CI: -1.00 to -0.51; P < .00001), and stay in hospital (WMD = -2.71 days; 95% CI: -4.54 to -0.88; P = .004), despite similar operating time (WMD = 11.17 minutes; 95% CI: -14.37 to 36.70; P = .39).

Conclusions: Laparoscopic resection might be a technically safe and feasible approach for mid-low rectal cancer patients after nCRT compared with open resection.

Keywords: laparoscopic resection; meta-analysis; neoadjuvant chemoradiotherapy; rectal cancer.

Publication types

  • Comparative Study
  • Meta-Analysis
  • Review

MeSH terms

  • Chemoradiotherapy, Adjuvant
  • Gastrointestinal Tract / physiology
  • Humans
  • Laparoscopy* / adverse effects
  • Length of Stay
  • Lymph Node Excision
  • Neoadjuvant Therapy
  • Operative Time
  • Postoperative Complications / etiology
  • Recovery of Function
  • Rectal Neoplasms / therapy*
  • Treatment Outcome